Utilty of analitical parameters in the diagnosis of liver diseases;Utilidad de los parámetros analíticos en el diagnóstico de las enfermedades hepáticas

Anales de Medicina Interna

Volumn 24, Issue 1, 2007, Pages 38-46

  Moreno Borque, A ^a   Gonzalez Moreno L ^b   Mendoza Jimenez J ^b   Garcia Buey L ^b   Moreno Otero, Ricardo ^b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Alkaline phosphatase; ALT; AST; Autoimmune hepatitis; Gamma glutamil transpeptidase; Hepatitis B virus; Hepatitis C virus; Liver function test

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; IRON; PROTHROMBIN;

ACUTE DISEASE; ADVERSE OUTCOME; ALCOHOLIC FATTY LIVER; ANALYTIC METHOD; ANAMNESIS; BILE DUCT OBSTRUCTION; CHEMICAL PARAMETERS; CHOLESTASIS; CHRONIC LIVER DISEASE; CRIGLER NAJJAR SYNDROME; CYTODIAGNOSIS; DIAGNOSTIC APPROACH ROUTE; DUBIN JOHNSON SYNDROME; ECHOGRAPHY; ENZYME BLOOD LEVEL; GILBERT DISEASE; HEMOCHROMATOSIS; HUMAN; HYPERBILIRUBINEMIA; LIVER BIOPSY; LIVER DISEASE; LIVER FUNCTION TEST; NON INVASIVE MEASUREMENT; NONALCOHOLIC FATTY LIVER; PHYSICAL EXAMINATION; REVIEW; SCREENING TEST; VIRUS HEPATITIS; BLOOD; PROSPECTIVE STUDY;

HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; PROSPECTIVE STUDIES;

EID: 34250312139     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Scola RH, Werneck LC, Prevedello DM, Toderke EL, Iwamoto FM. Diagnosis of dermatomyositis and polymyositis: a study of 102 cases. Arq Neuropsiquiatr 2000; 58: 789-99.
2. Lin YC, Lee WT, Huang SF, Young C, Wang PJ, Shen YZ. Persistent hypertransaminasemia as the presenting findings of muscular dystrophy in childhood. Acta Paediatr Taiwan 1999; 40: 424-9.
3. Mathiesen UL, Franzen LE, Fryden A, Foberg U, Bodemar G. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol 1999; 34: 85-91.
4. Lewis JH. Drug-induced liver disease. Med Clin North Am 2000; 84: 1275-311, x.
5. McQuillan GM, Townsend TR, Fields HA, Carroll M, Leahy M, Polk BF. Seroepidemiology of hepatitis B virus infection in the United States. to 1980. Am J Med 1989; 87: 5S-10S.
6. Proceedings of the European Association for the Study of the Liver International Consensus Conference on Hepatitis B. September 14-16, Geneva, Switzerland. J Hepatol 2003;39 Suppl 1: S1-235.
7. Czaja AJ. Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci 1995; 40: 435-56.
8. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996; 334: 897-903.
9. Soloway RD, Summerskill WH, Baggenstoss AH, Geall MG, Gitnick GL, Elveback IR, et al. Clinical, biochemical, and histological remission of severe chronic liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972; 63: 820-33.
10. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33: 99-103.
11. Mistilis SP, Skyring AP, Blackburn CR. Natural history of active chronic hepatitis. I. Clinical features, diagnostic criteria, morbidity, mortality and survival. Australas Ann Med 1968; 17: 214-23.
12. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001; 121: 710-23.
13. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
14. Amberg JM, Schneiderman LJ, Berry CC, Zettner A. The abnormal outpatient chemistry panel serum alkaline phosphatase: analysis of physician response, outcome, cost and health effectiveness. J Chronic Dis 1982; 35: 81-8.
15. Lieberman D, Phillips D. "Isolated" elevation of alkaline phosphatase: significance in hospitalized patients. J Clin Gastroenterol 1990; 12: 415-9.
16. Sorbi D, McGill DB, Thistle JL, Therneau TM, Henry J, Lindor KD. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am J Gastroenterol 2000; 95: 3206-10.
17. Moussavian SN, Becker RC, Piepmeyer JL, Mezey E, Bozian RC. Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease. Dig Dis Sci 1985; 30: 211-4.
18. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996; 347: 578-81.
19. Doumas BT, Peters T, Jr. Serum and urine albumin: a progress report on their measurement and clinical significance. Clin Chim Acta 1997; 258 (1): 3-20.
20. Harrison PM, O'Grady JG, Keays RT, Alexander GJ, Williams R. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. Bmj 1990; 301: 964-6.
21. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123: 1367-84.